Overview

An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma

Status:
Recruiting

Trial end date:
2024-05-15

Target enrollment:

Participant gender:

Summary

This is an open-label, single-arm, multicenter phase II clinical study to preliminarily observe and evaluate the efficacy and safety of Toripalimab combined with TACE in the treatment of extrahepatic cholangiocarcinoma.

Phase:

Phase 2

Details

Lead Sponsor:

Xuhua Duan

Treatments:

Gemcitabine
Oxaliplatin